-
First-of-its-Kind Bio-Artificial Pancreas on Track for Type-I Diabetes Cure
Leading biomedical company Beta-O2 Technologies gearing up to start second round of human clinical trials within the year on heels of promising preliminary results Boston, MA — Imagine a world where those living with Type 1 Diabetes, a chronic illness affecting more than 60 million adults globally, no longer had…
-
Biomarker identified for early beta cell death in Type 1 diabetes
Beta cells in the pancreas produce insulin. Their death is a key feature of Type 1 diabetes, and that loss starts long before diagnosis. However, there has been no straightforward way to measure that early loss. Anath Shalev, M.D., and colleagues at the University of Alabama at Birmingham now have…
